Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07FCB
|
||||
Former ID |
DNC007498
|
||||
Drug Name |
4-phenyl-1-(1-phenylethyl)piperidin-4-ol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528785] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H23NO
|
||||
Canonical SMILES |
CC(C1=CC=CC=C1)N2CCC(CC2)(C3=CC=CC=C3)O
|
||||
InChI |
1S/C19H23NO/c1-16(17-8-4-2-5-9-17)20-14-12-19(21,13-15-20)18-10-6-3-7-11-18/h2-11,16,21H,12-15H2,1H3
|
||||
InChIKey |
PKTJCXJTMHJHNK-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [528785] | |
Nociceptin receptor | Target Info | Inhibitor | [528785] | ||
Kappa-type opioid receptor | Target Info | Inhibitor | [528785] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Opioid prodynorphin pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.